Clinical Reference Library
RENOVÓ Documentation
Six reference documents covering the RENOVÓ platform — sourcing and standards, each formulation line, and protocol selection. The clinical peptide portfolio is supplied to verified partner practices on application.
I
Foundation Reference
Platform Document
The complete RENOVÓ biologics platform — all five categories, sourcing philosophy, quality standards, and full product reference table.
II
Product Line
EXO Line
Complete overview of the exosome formulation line — EXO-30, EXO-50, EXO-90, and EXO-180 — including source environments, specifications, and clinical contexts.
III
Product Line
Wharton's Jelly Line
Complete overview of the Wharton's Jelly structural matrix line — WJ-75, WJ-95, WJ-150, and WJ-300 — including formulation contexts and selection guidance.
IV
Product Line
Conditioned Media Line
Complete overview of the conditioned media line — CM-1 and CM-2 — including the distinction between vesicular and soluble signalling and clinical application contexts.
V
Clinical Reference
Clinical Protocol Guide
The complete clinical selection framework — biological roles, protocol selection by category, combination logic, decision framework, and patient communication guidance.
VI
Partnership
Clinic Partnership Overview
Introduction to the RENOVÓ clinical partnership programme — platform overview, quality standards, clinical categories, and how to apply for a clinical account.
VII
Clinical Access Only
Peptide Portfolio
RENOVÓ supplies a clinical peptide portfolio to verified partner practices. US manufactured to a minimum 99% purity specification, with Certificate of Analysis documentation on every batch. The portfolio is not listed publicly — it is disclosed in writing on approval, and ordered by request against a practitioner licence.
99%+Purity Specification
USManufactured
COAEvery Batch